Baxion
ScreeningTagsAlerts

Attovia Therapeutics, Inc.

ATTO

Financials

10-QQuarter ended 06/30/2609/02/26

Disclosures

8-KCurrent report09/02/268-KCurrent report08/06/26

Prospectuses and Registrations

S-8Registration of securities for employees08/06/26424B4Prospectus08/05/26S-1/ARegistration statement (amended)08/04/26S-1/ARegistration statement (amended)07/29/26S-1Registration statement (IPO)07/14/26

Proxies

No matching filings.

Ownership

3/AInitial insider ownership (amended)10/08/263/AInitial insider ownership (amended)10/08/264/AInsider transaction (amended)10/08/264/AInsider transaction (amended)10/08/26144Proposed sale of securities08/28/26

Other

CERTCEO/CFO certification08/04/26EFFECTRequest for effectiveness08/04/268-A12B8-A12B07/29/26DRS/ADRS/A06/05/26DRS/ADRS/A02/12/26

Latest Filings

10-QQuarter ended 06/30/2609/02/268-KCurrent report09/02/268-KCurrent report08/06/26S-8Registration of securities for employees08/06/26424B4Prospectus08/05/26

Ownership

3/AInitial insider ownership (amended)10/08/263/AInitial insider ownership (amended)10/08/264/AInsider transaction (amended)10/08/264/AInsider transaction (amended)10/08/26144Proposed sale of securities08/28/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact